Everything Dr. Linda Strauss said on any show that made the record, most notable first. Each card names its show and opens the statement there.
Psilocybin breaks neural connections so follow-on psychotherapy can rewire them
“So if you think about a psychedelic trip, you can imagine that the psilocybin breaks apart those neural connections and then follow on psychotherapy Will reconnect them in a, air quote, healthier way.”
The FDA will not approve psychedelic medicines without accompanying talk therapy
“I don't see the FDA, by the way, Sean, a hundred percent. I don't see the FDA approving any of this that isn't in combination with some form of talk therapy.”
Psychedelics are pursuing FDA clinical pathways much more than cannabis did
“I see A lot more activity on the regulated pathway, whereas cannabis has clearly taken the adult use pathway with very few products that have moved into that space with Epidiolex being the exception to the rule.”
Serious psilocybin side effects are linked to 5-HT receptor binding
“Now there is some side effects, serious side effects that have emerged with psilocybin due to its binding to the five HT The two B receptor. It's either the two A receptor, the two B receptor.”
Areas with cannabis dispensaries see lower rates of opioid use disorder
“There's a great study, I want to say it's out of UC Davis, that's literally shown a slightly different crisis, but the opioid overuse, you know, substance abuse diseases, an opioid use that's shown that in areas where there's cannabis dispensaries, there's a l…”
EI Ventures is developing a transdermal delivery patch for psilocybin
“In a press release, it's publicly announced that we are, at EI Ventures, are working with a contract research organization to develop a transdermal psilocybin patch, ultimately.”
Current antidepressant use is an exclusion criterion in psychedelic clinical trials
“Being on an antidepressant so far is an exclusionary criteria in probably all the clinical trials right now.”
Psilocybin mushrooms are actually easier to cultivate than cannabis plants
“Mushrooms are actually easier than cannabis to grow”
FDA package inserts directly mirror clinical trial design and adverse events
“If you read that package insert,
You could write an entire drug development pathway for that product because who it's indicated for were all the inclusion exclusion criterias that were there.
All the side effects were all the adverse events that were collected…”
WE LIVE TO BUILDLEDGER